Gene · 7003
Papers2,415
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 2,415
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterization of sequence determinants of enhancer function using natural genetic variation. | Elife | 2022 | 36043696 | PubTator, text mining | PubMed |
| Sirtuin 6 protects against hepatic fibrogenesis by suppressing the YAP and TAZ function. | FASEB J | 2022 | 36036554 | PubTator, text mining | PubMed |
| Advances in prognostic and therapeutic targets for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The hippo signaling pathway. | Front Oncol | 2022 | 36033517 | PubTator, text mining | PubMed |
| CircMAT2B Induced by TEAD1 Aggravates the Warburg Effect and Tumorigenesis of Oral Squamous Cell Carcinoma through the miR-942-5p/HSPD1 Axis. | J Oncol | 2022 | 36016581 | PubTator, text mining | PubMed |
| Two Novel Genera, Neostemphylium and Scleromyces (Pleosporaceae) from Freshwater Sediments and Their Global Biogeography. | J Fungi (Basel) | 2022 | 36012856 | PubTator, text mining | PubMed |
| Expression of Key Factors of the Hippo Signaling Pathway in Yak (Bos grunniens) Mammary Gland. | Animals (Basel) | 2022 | 36009693 | PubTator, text mining | PubMed |
| CK2-induced cooperation of HHEX with the YAP-TEAD4 complex promotes colorectal tumorigenesis. | Nat Commun | 2022 | 36008411 | PubTator, text mining | PubMed |
| Single-cell analysis of hepatoblastoma identifies tumor signatures that predict chemotherapy susceptibility using patient-specific tumor spheroids. | Nat Commun | 2022 | 36008377 | PubTator, text mining | PubMed |
| Both YAP1-MAML2 and constitutively active YAP1 drive the formation of tumors that resemble NF2 mutant meningiomas in mice. | Genes Dev | 2022 | 36008139 | PubTator, text mining | PubMed |
| A Boolean approach for novel hypoxia-related gene discovery. | PLoS One | 2022 | 36006949 | PubTator, text mining | PubMed |
| DNA methylome and single-cell transcriptome analyses reveal CDA as a potential druggable target for ALK inhibitor-resistant lung cancer therapy. | Exp Mol Med | 2022 | 35999456 | PubTator, text mining | PubMed |
| Metadata analysis to explore hub of the hub-genes highlighting their functions, pathways and regulators for cervical cancer diagnosis and therapies. | Discov Oncol | 2022 | 35994213 | PubTator, text mining | PubMed |
| Paraphoma garibaldii sp. nov. causing leaf spot disease of Campanula rapunculoides in Italy. | Fungal Syst Evol | 2022 | 35978988 | PubTator, text mining | PubMed |
| Taxonomy and Multi-Gene Phylogeny of Poroid Panellus (Mycenaceae, Agaricales) With the Description of Five New Species From China. | Front Microbiol | 2022 | 35966669 | PubTator, text mining | PubMed |
| TRABID targets DDB2 for deubiquitination to promote proliferation of hepatocellular carcinoma cells. | Biochem Biophys Res Commun | 2022 | 35944360 | PubTator, text mining | PubMed |
| Screening and identification of immune-related genes for immunotherapy and prognostic assessment in colorectal cancer patients. | BMC Med Genomics | 2022 | 35941638 | PubTator, text mining | PubMed |
| A single-cell based precision medicine approach using glioblastoma patient-specific models. | NPJ Precis Oncol | 2022 | 35941215 | PubTator, text mining | PubMed |
| CRISPR Activation Screening Identifies VGLL3-TEAD1-RUNX1/3 as a Transcriptional Complex for PD-L1 Expression. | J Immunol | 2022 | 35922063 | PubTator, text mining | PubMed |
| Circular RNA circTTBK2 facilitates non-small-cell lung cancer malignancy through the miR-873-5p/TEAD1/DERL1 axis. | Epigenomics | 2022 | 35916080 | PubTator, text mining | PubMed |
| Clinical potential of the Hippo-YAP pathway in bladder cancer. | Front Oncol | 2022 | 35912245 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7003/papers?page=38